The Food and Drug Administration (FDA) draft Guidance (Guidance) addressing the content and format of Dear Health Care Provider (DHCP) letters—which are sometimes called “Dear Doctor” letters—is the first substantive guidance from FDA on this issue.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact customerservices@lexology.com
RegisterFDA draft guidance on Dear Health Care Provider letters carries potentially significant products liability implications
To view this article you need a PDF viewer such as Adobe Reader.
USA
November 19 2010
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email enquiries@lexology.com.
Power up your legal research now
Find everything you need in our powerful new research hub.
Featured Video
Related topic hubs
Terry V Thiele
Director, Sustainable Product Strategies
The Lubrizol Corporation
What our clients say
"The problem with the information age is that it leaves one drinking from a firehose. The service succeeds in reducing that torrent to manageable gulps of high value analyses addressing topics of immediacy. "